Aptose Biosciences INC. (APTOF) SEC Filings — 2025
50 SEC filings for Aptose Biosciences INC. (APTOF) in 2025.
Filings
- Aptose Biosciences Files 8-K — 8-K · Dec 19, 2025
- Aptose Biosciences Files 8-K with Regulatory Updates — 8-K · Dec 8, 2025
- Aptose Biosciences Inc. Signs Material Definitive Agreement — 8-K · Nov 25, 2025
- Aptose Biosciences Files 8-K — 8-K · Nov 19, 2025
- Aptose's Cash Dries Up, Going Concern Doubts Mount Amid Nasdaq Delisting — 10-Q · Nov 13, 2025
- Aptose Biosciences Files 8-K on Financials — 8-K · Nov 13, 2025
- Aptose Biosciences Files 8-K — 8-K · Nov 3, 2025
- Aptose Biosciences Files 8-K Report — 8-K · Oct 16, 2025
- Aptose Biosciences Files 8-K — 8-K · Sep 22, 2025
- Aptose Biosciences Inc. Announces Board and Officer Changes — 8-K · Aug 27, 2025
- Aptose Biosciences Files 8-K — 8-K · Aug 25, 2025
- Aptose Biosciences Files 8-K — 8-K · Aug 22, 2025
- Aptose Biosciences Files 8-K with Regulatory Updates — 8-K · Aug 18, 2025
- Aptose Biosciences Files 8-K on Financials — 8-K · Aug 13, 2025
- Aptose's Cash Dries Up, Nasdaq Delisting Confirmed Amid Mounting Losses — 10-Q · Aug 13, 2025
- Aptose Biosciences Files 8-K — 8-K · Aug 6, 2025
- Aptose Biosciences Files Proxy Materials — DEFA14A · Aug 1, 2025
- Aptose Biosciences Files 8-K — 8-K · Jul 15, 2025
- Aptose Biosciences Inc. Enters Material Definitive Agreement — 8-K · Jul 2, 2025
- Aptose Biosciences Files 8-K — 8-K · Jul 1, 2025
- Aptose Biosciences Enters Material Definitive Agreement — 8-K · Jun 26, 2025
- Aptose Biosciences Files 8-K on June 20, 2025 — 8-K · Jun 20, 2025
- Aptose Biosciences Inc. Announces Board and Compensation Changes — 8-K · Jun 18, 2025
- Aptose Biosciences Inc. Files 8-K Report — 8-K · Jun 17, 2025
- Aptose Biosciences Files 8-K — 8-K · Jun 12, 2025
- Aptose Biosciences Files 8-K — 8-K · May 28, 2025
- Aptose Biosciences Files 8-K — 8-K · May 20, 2025
- Aptose Biosciences Files 8-K — 8-K · May 14, 2025
- Aptose Biosciences Files 8-K on Financials — 8-K · May 8, 2025
- Aptose Biosciences Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Aptose Biosciences Files 8-K — 8-K · May 5, 2025
- Aptose Biosciences DEF 14A: Executive Comp & Equity Awards — DEF 14A · Apr 28, 2025
- Aptose Biosciences Files 8-K — 8-K · Apr 23, 2025
- Aptose Biosciences Changes Auditors — 8-K · Apr 21, 2025
- Aptose Biosciences Faces NASDAQ Delisting Notice — 8-K · Apr 3, 2025
- Aptose Biosciences Inc. Files 8-K — 8-K · Apr 1, 2025
- Aptose Biosciences Files 8-K on Financials — 8-K · Mar 28, 2025
- Aptose Biosciences Files 2024 10-K — 10-K · Mar 28, 2025
- Aptose Biosciences Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 24, 2025
- Aptose Biosciences Files 8-K — 8-K · Mar 17, 2025
- Aptose Biosciences Files 8-K with Exhibits — 8-K · Mar 12, 2025
- Aptose Biosciences Files 8-K on Security Holder Rights — 8-K · Feb 21, 2025
- Aptose Biosciences Inc. Files 8-K Report — 8-K · Feb 20, 2025
- Aptose Biosciences Files 8-K — 8-K · Feb 18, 2025
- Aptose Biosciences Inc. Files 8-K: Material Agreement & Equity Sales — 8-K · Feb 13, 2025
- Aptose Biosciences Files 8-K — 8-K · Feb 13, 2025
- Aptose Biosciences Inc. Files 8-K — 8-K · Feb 12, 2025
- Aptose Biosciences Inc. Files 8-K for Material Agreement — 8-K · Feb 3, 2025
- Aptose Biosciences Inc. Files 8-K on Shareholder Vote Matters — 8-K · Jan 28, 2025
- Aptose Biosciences Faces Delisting Concerns — 8-K · Jan 21, 2025